The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Researchers Seek ANCA-Associated Vasculitis Subtype Markers

Researchers Seek ANCA-Associated Vasculitis Subtype Markers

October 19, 2020 • By Larry Beresford

  • Tweet
  • Email
Print-Friendly Version / Save PDF
alphaspirit / shutterstock.com

alphaspirit / shutterstock.com

New research on complement activation in anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis underscores its important role in the patho­genesis of this disease, an autoimmune condition defined by inflammation of small- and medium-caliber blood vessels.1 ANCA testing is commonly performed to help diagnose granulomatosis with polyangiitis and microscopic polyangiitis, both of which are forms of ANCA-associated vasculitis.

You Might Also Like
  • Researchers Seek the Best Methods to Maintain Remission in Vasculitis
  • Research Shows Genetic Links in ANCA-Associated Vasculitis
  • ANCA-Associated Vasculitis Trial Results May Change Standard of Care
Explore This Issue
October 2020
Also By This Author
  • Doctors & Political Advocacy: Tips to Get You Started

Two main types of ANCA-associated vasculitis exist: MPO-ANCA, defined by the presence of antibodies against myeloper­oxidase, and PR3-ANCA, defined by the presence of antibodies against proteinase 3. These differ in genetic predisposition, pathophysiologic mechanism, cytokine profile, organ predilection and treatment response, which makes phenotyping important, says one of the study’s authors, Eveline Wu, MD, MSCR, an allergist/immunologist, pediatric rheumatologist and researcher at the University of North Carolina (UNC), Chapel Hill.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We know complement is an important part of our innate immune system, defending against microbes or pathogens while ‘complementing’ other parts of the immune system,” Dr. Wu says. “It is a complex process, involving more than 30 proteins that act sequentially, creating a cascade.” Complement can be activated in three different ways, via the alternative, classical and lectin pathways, although for this condition the alternative pathway may be more important. The pathways converge at C3.

A Critical Role in ANCA

Historically, complement activation was not thought to have a significant role in ANCA-associated vasculitis, because there is typically little immunoglobulin or complement deposition at the site of tissue injury. An experimental mouse model of ANCA-associated vasculitis was developed at UNC, with injection of the anti-MPO antibody producing a vasculitis similar to microscopic polyangiitis.2 The investigators discovered that mice deficient in certain complement components were protected from developing the condition, which was the start of accumulating evidence showing complement activation is, in fact, critical in ANCA-associated vasculitis, as well as in certain other autoimmune conditions.3

Dr. Wu

Dr. Wu

“The primary objective of our study was to investigate complement activation in human MPO-ANCA and PR3-ANCA-associated vasculitis,” the authors note. A secondary objective was to determine whether FUTHAN, a broad-specificity protease inhibitor that blocks in vitro complement activation, could aid in more accurately measuring complement activation in patients with ANCA-associated vasculitis and healthy controls, given the risk for complement activation caused by sampling procedures.

Plasma from 98 patients with ANCA-associated vasculitis and 35 healthy controls was obtained and immediately frozen. ELISA measures and Wilcoxon two sample tests were conducted to compare plasma levels of circulating complement activation products among groups. Levels of C3a, C5a and sC5b-9 were found to be higher in active MPO-ANCA-associated vasculitis patients than in healthy controls, and C3a, C5a, sC5b-9 and C4d were higher in active PR3-ANCA-associated vasculitis patients than in healthy controls.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Vasculitis Tagged With: avacopan, Biomarkers, complement activation, eculizumabIssue: October 2020

You Might Also Like:
  • Researchers Seek the Best Methods to Maintain Remission in Vasculitis
  • Research Shows Genetic Links in ANCA-Associated Vasculitis
  • ANCA-Associated Vasculitis Trial Results May Change Standard of Care
  • ANCA-Associated Vasculitis in Systemic Sclerosis

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)